Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mark Hopman

Chief Commercial Officer at Beta Bionics, Inc. (BBNX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 5SEC BBNXBeta Bionics, Inc. Sell Plan 37056,109 held (−1%) $18.96 $7K -7.0%
Sep 18SEC BBNXBeta Bionics, Inc. Sell Plan 35,99488,033 held (−29%) $18.46 $664K -4.5%
Sep 17SEC BBNXBeta Bionics, Inc. Sell Plan 30,77956,479 held (−35%) $20.13 $620K -12.4%
Sep 15SEC BBNXBeta Bionics, Inc. Sell Plan 77586,382 held (−1%) $15.52 $12K +13.6%
Sep 10SEC BBNXBeta Bionics, Inc. Sell Plan 36,87087,157 held (−30%) $18.46 $681K -4.5%
Sep 3SEC BBNXBeta Bionics, Inc. Sell 5,327124,027 held (−4%) $19.11 $102K -7.7%
Jun 25SEC BBNXBeta Bionics, Inc. Sell Plan 1,258129,354 held (−1%) $15.01 $19K +17.5%
Jun 5SEC BBNXBeta Bionics, Inc. Sell Plan 275130,612 held (−0%) $12.31 $3K +43.2%
Jun 3SEC BBNXBeta Bionics, Inc. Sell 5,329130,887 held (−4%) $12.61 $67K +39.8%
Mar 16SEC BBNXBeta Bionics, Inc. Sell Plan 856138,277 held (−1%) $29.34 $25K -39.9%
Mar 16SEC BBNXBeta Bionics, Inc. Sell Plan 2,061136,216 held (−1%) $30.66 $63K -42.5%
Mar 5SEC BBNXBeta Bionics, Inc. Sell Plan 353139,133 held (−0%) $11.57 $4K +52.4%
Mar 3SEC BBNXBeta Bionics, Inc. Sell 834139,486 held (−1%) $12.36 $10K +42.6%
  • Sell

    Chief Commercial Officer Mark Hopman sold $7K of BBNX at $18.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Mark Hopman sold $664K of BBNX at $18.46 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Mark Hopman sold $620K of BBNX at $20.13 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Mark Hopman sold $12K of BBNX at $15.52 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Mark Hopman sold $681K of BBNX at $18.46 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Mark Hopman sold $19K of BBNX at $15.01 — pre-scheduled 10b5-1 plan sale.